Frontlight ResearchEarly access
TerminatedPhase 2
Massage for Prostate Cancer-Related Fatigue (mPROSTATE)
Key facts
- Who runs it
- University of Utah
- Where
- Salt Lake City, United StatesSee the site
- Trial code
- Status
- Terminated
- Phase
- Phase 2
- People taking part
- 28 people enrolled
- Started
- 17 Jun 2022
- Ended
- 2 Aug 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Swedish Massage Therapy (SMT)
- Light Touch (LT) Control
- Waitlist Control (WLC)
- Record updated
- 13 July 2026
- Why it stopped
- Lack of Funding
Who can take part
- Age
- 45 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Male subjects aged >= 45 years old
- Histologically confirmed diagnosis of prostate cancer
- Subjects must have completed radiation therapy >= 2 months, prior to registration
- Subjects who have a score > 25 on the Brief Fatigue Inventory (BFI) at screening
- Subjects who are fluent in speaking and reading English
- Based on International Classification of Diseases (ICD)-10 proposed criteria, the patient must have a diagnosis of CRF with evidence from the history, physical exam, and laboratory findings that the fatigue is a consequence of cancer or cancer therapy and not primarily a consequence of any of the following:; Comorbid psychiatric disorders; Anemia (hemoglobin less than 10 g/dl); Hypothyroidism (thyroid stimulating hormone (TSH) greater than 4.6 micro-international units (uIU)/mL); Uncontrolled pain; Any medical or psychiatric condition or medication felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment. These medical circumstances may include:; The use of medications such as opioids, sedating anti-histamines, or neuroleptics; Medical problems associated with fatigue: chronic obstructive pulmonary disease, congestive heart failure, renal disease, hepatic dysfunction, uncontrolled autoimmune disease, neurological disorders such as multiple sclerosis or Parkinson's disease, and sleep apnea
- Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines
Who cannot take part
- Current use of any medications or therapies listed as prohibited in Section 6.6.1
- Treatment with corticosteroids or other immunosuppressants =< 6 months prior to registration, , unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement
- Regular use of anti-inflammatory drugs including non-steroidal anti-inflammatory drugs and natural products thought to have anti-inflammatory properties, unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement
- Change in prescribed dose of medications for anxiety or depression =< 4 weeks prior to registration
- Change in fluoxetine dose within =< 8 weeks prior to registration
- Other conditions or behaviors that, in the opinion of the treating investigator, may negatively impact study participation, including the following:; Illicit drug use; Shift work; Current dieting; Excessive regular use of alcohol (more than two 5-ounce glasses of wine or equivalents/day); Any instance of binge drinking (more than 7 drinks in a 24-hour period) =< 6 months prior to registration
- Subjects meeting criteria for a current substance use diagnosis or current diagnoses of schizophrenia, depression, generalized anxiety disorder, bipolar disorder, dementia, delirium, or obsessive compulsive disorder (OCD)
- Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol, or complete the study
- Inability to lay prone comfortably for 25 minutes and inability to lay supine comfortably for 25 minutes, given the nature of the massage intervention
- Body-mass index less than 18.5 (kg/m\^2)
- Subjects who cannot comply with the protocol for any reason
- Subjects who are actively suicidal or homicidal
- Current and/or past use of massage for the treatment of fatigue
Where in United States
- Huntsman Cancer Institute/University of UtahSalt Lake City, United States
About the trial
What the trial wants to find out
This phase II trial investigates the effect of massage in decreasing prostate cancer-related fatigue. Massage therapy has well known health benefits. This trial aims to find out if massage and touch therapies reduce fatigue due to cancer, and to learn if these therapies are better than traditional medicine or psychology for cancer related fatigue.
The 3 groups in the trial
- Swedish Massage Therapy (SMT)Treatment being tested
Patients receive SMT over 45 minutes once weekly for 6 weeks.
- Light Touch (LT)Sham treatment, for comparison
Patients receive LT over 45 minutes once weekly for 6 weeks.
Treatment: Light Touch (LT) Control
- Waitlist Control (WLC)Existing treatment, for comparison
Patients will sit and relax for 45 minutes before completing study assessments at weeks 3 and 6.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 July 2026